Together Pharma Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.22	8.44	3.59	5.3	5.1
Cash & Short-Term Investments	12.22	8.44	3.59	5.3	5.1
Cash Growth	44.71%	135.08%	-32.17%	3.94%	-11.51%
Accounts Receivable	14.96	16.99	12.63	8.35	0.91
Other Receivables	2.32	2.55	0.44	0.09	0.22
Receivables	17.29	19.54	13.06	8.44	1.13
Inventory	63.24	56.38	55.26	44.59	46.53
Prepaid Expenses	1.27	0.14	0.37	0.99	0.41
Other Current Assets	-	-	0.45	-	34.08
Total Current Assets	94.01	84.5	72.74	59.31	87.24
Property, Plant & Equipment	33.06	35.47	35.44	36.59	34.8
Long-Term Investments	-	-	-	0.1	-
Goodwill	16.18	16.18	16.18	16.18	16.18
Other Intangible Assets	8.24	8.54	12	15.43	18.43
Other Long-Term Assets	2.49	2.37	2.2	2.2	2
Total Assets	153.98	147.05	138.55	129.79	158.65
Accounts Payable	17.94	21.36	13.76	9.36	6.21
Accrued Expenses	6.35	4.55	6.82	5.12	2.92
Short-Term Debt	28.37	27.48	11.89	15.59	6.21
Current Portion of Long-Term Debt	4.04	14	17.35	6.09	39.69
Current Portion of Leases	1.48	1.48	1.56	1.4	0.62
Current Unearned Revenue	-	-	-	-	0.3
Other Current Liabilities	13.13	9.95	10.84	9.77	10.24
Total Current Liabilities	71.3	78.82	62.22	47.32	66.19
Long-Term Debt	15.11	9.73	13.31	25.97	29.77
Long-Term Leases	10.75	10.87	10.69	11.02	9.08
Pension & Post-Retirement Benefits	-	-	-	-	0.04
Long-Term Deferred Tax Liabilities	4.8	3.45	3.99	-	-
Other Long-Term Liabilities	1.89	5.97	50.88	42.45	27.86
Total Liabilities	103.84	108.84	141.1	126.77	132.94
Common Stock	251.76	239.76	194.62	197.39	183.96
Retained Earnings	-211.23	-213.14	-211.97	-207.65	-174.13
Comprehensive Income & Other	7.49	6.7	9.56	9.83	10.79
Total Common Equity	48.03	33.32	-7.79	-0.43	20.63
Minority Interest	2.11	4.89	5.24	3.45	5.08
Shareholders' Equity	50.14	38.21	-2.55	3.02	25.71
Total Liabilities & Equity	153.98	147.05	138.55	129.79	158.65
Total Debt	59.75	63.57	54.8	60.08	85.37
Net Cash (Debt)	-47.53	-55.12	-51.21	-54.78	-80.27
Net Cash Per Share	-3.01	-4.44	-5.83	-6.72	-11.72
Filing Date Shares Outstanding	17.35	13.81	8.79	8.79	7.53
Total Common Shares Outstanding	17.35	13.81	8.79	8.79	7.43
Working Capital	22.71	5.68	10.51	11.99	21.05
Book Value Per Share	2.77	2.41	-0.89	-0.05	2.78
Tangible Book Value	23.61	8.61	-35.97	-32.03	-13.98
Tangible Book Value Per Share	1.36	0.62	-4.09	-3.65	-1.88
Machinery	20.66	19.4	18.16	17.33	17
Leasehold Improvements	13.86	15.41	14.53	14.22	13.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.